Concepedia

Mark Semenuk

MS

Statistics

Publications

5

Citations

475

H-Index

5

Active since

1996

Affiliations

Human Genome Sciences (United States)(Current)

Mark Semenuk is an author at Human Genome Sciences (United States) specializing in microbiology, clinical microbiology, and vaccine development.

Top concepts

Publications per year

1996–2003

5

Publications

5

Interferon-κ, a Novel Type I Interferon Expressed in Human Keratinocytes

David W. LaFleur, Bernardetta Nardelli, Tatiana Tsareva et al. · Journal of Biological Chemistry · 2001 · 278 citations · Full text

Regulatory Effect of IFN-κ, A Novel Type I IFN, On Cytokine Production by Cells of the Innate Immune System

Bernardetta Nardelli, Liubov Zaritskaya, Mark Semenuk et al. · The Journal of Immunology · 2002 · 87 citations

A Noncovalent Complex Vaccine Prepared with Detoxified Escherichia coli J5 (Rc Chemotype) Lipopolysaccharide and Neisseria meningitidis Group B Outer Membrane Protein Produces Protective Antibodies against Gram-Negative Bacteremia

A. K. Bhattacharjee, Steven M. Opal, Robert M. Taylor et al. · The Journal of Infectious Diseases · 1996 · 60 citations · Full text

, , +16

Dendritic cells and MPIF-1: chemotactic activity and inhibition of endogenous chemokine production by IFN-γ and CD40 ligation

Bernardetta Nardelli, Diana K. Morahan, Gary W. Bong et al. · Journal of Leukocyte Biology · 1999 · 27 citations

DcR3/TR6 modulates immune cell interactions

Xiaochun Wan, Guixiu Shi, Mark Semenuk et al. · Journal of Cellular Biochemistry · 2003 · 23 citations

1–5 of 5